The Link Between Migraine and Stroke: A Detailed Exploration

Most people think of migraines as severe headaches that eventually pass. But in rare cases, a migraine attack can cross into far more dangerous territory – triggering an actual stroke. This is known as a migrainous infarction, or migraine stroke, and it represents one of the most serious neurological complications that can arise from a migraine episode. Understanding what it is, who is at risk, and why it happens is essential for anyone managing recurring migraines, especially those who experience aura.

What is a migraine stroke? 🔗

A migrainous infarction is technically defined as a migraine attack occurring as migraine with aura, where one or more aura symptoms persist for more than 60 minutes and neuroimaging confirms an ischemic infarct in the region corresponding to those symptoms. In other words, it is not just a migraine that looks like a stroke – it is an actual stroke that occurs during the course of a migraine episode, in the same brain region producing the aura symptoms.

According to research published in PubMed, migrainous infarction accounts for approximately 0.5-1.5% of all ischemic strokes. While that figure sounds small, it translates to a meaningful population given how common migraines are globally. A 2024 review in Frontiers in Neurology estimated that migraine affects up to 20% of the global population and ranks as the second leading cause of disability worldwide, which means even a rare complication has broad reach.

Patients diagnosed with migrainous infarction tend to be younger than typical stroke patients. Studies report the average age at diagnosis between 29 and 39, with the incidence in females nearly double that of males. This youth skew makes it particularly important – a stroke in a young adult carries lifelong consequences.

How does a migraine turn into a stroke? 🔗

The exact mechanism behind migrainous infarction is still not fully understood, but several overlapping biological processes have been identified as likely contributors.

Cortical spreading depression 🔗

The most widely studied mechanism is cortical spreading depression (CSD) – a slow-moving wave of intense neuronal depolarization that sweeps across the brain’s cortex at roughly 3-5 mm per minute. Research from the journal of Cerebral Blood Flow and Metabolism describes CSD as causing dramatic failures in brain ion balance, surges in oxygen demand, and significant changes in cerebral blood flow. It is widely considered the neurophysiological basis of migraine aura, since its propagation pattern matches the gradual spread of aura symptoms across the visual field.

In a healthy brain, CSD is typically a transient event with no lasting damage. But in a brain with pre-existing vascular vulnerability, the same wave can trigger extreme vasoconstriction rather than normal vasodilation, reducing blood flow to levels where ischemic injury occurs. This is the critical transition point where a migraine aura may convert into a stroke.

Vasospasm and blood vessel dysfunction 🔗

Vasospasm – the sudden, abnormal narrowing of blood vessels – is a key suspected trigger for migrainous infarction. During a migraine, the brain releases potent vasoconstrictive substances including endothelin and serotonin. Research published in Cephalalgia notes that vasospasm putatively results from the release of these vasoconstrictive molecules during the migraine attack, and that arteries in people with migraines are more likely to develop this type of spasm than those without migraine history.

A landmark case study and literature review in the Journal of Pain Research confirmed that among 119 documented cases of migrainous infarction, intracranial vasospasm was a recurring finding. The review concluded that arteries in people with migraine show impaired endothelial function, decreased vessel diameter, and heightened susceptibility to vasospasm – all of which increase stroke risk.

Hypercoagulability and platelet activation 🔗

Beyond blood vessel spasm, migrainous infarction mechanisms also include hypercoagulability – an elevated tendency for blood to clot. During migraine with aura, enhanced platelet activation has been directly observed, increasing the risk of thrombosis. The release of platelet-activating factor (PAF) during an attack further promotes clot formation and can contribute to vessel occlusion in the brain’s microvasculature.

Data suggest that in about 21% of migrainous infarction cases, thrombosis plays a direct role – with blood clots forming in a cerebral vessel during the attack, restricting blood flow and causing localized brain damage.

Who is most at risk? 🔗

Not all people with migraines face the same level of risk. Several factors significantly increase the likelihood of experiencing a migrainous infarction.

Migraine with aura 🔗

The strongest predictor is having migraine with aura. Approximately 80% of migrainous infarction patients had a prior history of migraine with aura. The International Headache Society (IHS) requires a confirmed aura history as part of the formal diagnostic criteria for the condition. Migraine without aura is associated with stroke too, but the link is considerably weaker and the risk much lower.

Female sex and hormonal contraceptives 🔗

Women under 45 with migraine with aura carry a notably elevated stroke risk. This risk becomes substantially higher when combined with the use of estrogen-containing oral contraceptives. A large population-based study published in the American Journal of Obstetrics and Gynecology found that women with migraine with aura using combined hormonal contraceptives had a 6-fold higher odds ratio for ischemic stroke compared to women with neither risk factor.

The mechanism is fairly direct: estrogen in combined oral contraceptives promotes blood clotting, which, when layered on top of a brain already prone to vasospasm and platelet activation during a migraine, creates a compounding risk. As neurologist Dr. Malathi Rao at Rush University Medical Center explains, estrogen can make blood clot more easily, and if that clot forms in an artery supplying the brain during a migraine, a stroke can result.

Because of this, the European Headache Federation and European Society of Contraception and Reproductive Health jointly advise against prescribing combined hormonal contraceptives – including pills, patches, and vaginal rings containing ethinylestradiol – to women with migraine with aura. Progestogen-only options are generally considered safer and have not been linked to the same arterial risk.

Smoking and additional vascular risk factors 🔗

Smoking compounds the stroke risk considerably. In documented cases of migrainous infarction, smoking frequently appeared as the sole additional vascular risk factor present. High blood pressure, obesity, and diabetes also raise the baseline risk, particularly in younger patients who might otherwise appear low-risk.

Recognizing a migraine stroke: symptoms and diagnosis 🔗

One reason migrainous infarction is so challenging to identify is that its early symptoms overlap significantly with a typical migraine aura. Aura itself includes transient visual disturbances, sensory changes, and sometimes speech difficulties – all of which are also warning signs of a stroke. The critical difference lies in persistence: aura symptoms typically last less than 60 minutes, but in migrainous infarction they persist beyond that threshold and do not resolve on their own.

The IHS diagnostic criteria require all of the following to be met: the patient must have a confirmed history of migraine with aura; at least one aura symptom must persist beyond 60 minutes during the attack; and brain imaging must confirm an ischemic lesion in the area corresponding to the symptom. Only 18% of people with migraine with aura will experience aura symptoms lasting longer than 60 minutes, so prolonged aura is itself a red flag that warrants urgent neuroimaging.

CT scans, MRI, and MR angiography are the primary tools used to locate and confirm brain lesions. Transcranial Doppler (TCD) ultrasound has also proven valuable for detecting intracranial vasospasm in real time, as demonstrated in several documented cases where vasospasm was identified and monitored during and after the infarction event.

Treatment and management 🔗

Managing a migrainous infarction follows the general framework for ischemic stroke, while incorporating migraine-specific considerations.

Acute treatment 🔗

Standard treatments for acute migrainous infarction include antiplatelet agents such as aspirin, and in some cases tissue plasminogen activator (tPA), which breaks down blood clots. Alteplase, a recombinant tPA, should be administered within 3 to 4.5 hours of onset for the best outcomes. When vasospasm is prominent, calcium channel blockers like verapamil have been used to reduce arterial spasm and restore blood flow.

Medications to avoid 🔗

A critical point in acute management is knowing what not to use. Triptans and ergotamines – common migraine-specific treatments – are contraindicated in migrainous infarction because they cause vasoconstriction and could worsen cerebral ischemia. Experts broadly recommend avoiding all vasoactive medications during an infarction episode, even when the headache is severe.

Long-term prevention 🔗

For ongoing management, antiplatelet therapy is generally recommended to reduce the risk of future ischemic events, alongside preventive migraine treatment. Calcium channel blockers and angiotensin receptor blockers are preferred for migraine prevention in these patients, as they also support endothelial repair and reduce vascular reactivity. Propranolol should be used with caution, and is best avoided in patients with prolonged aura or brainstem aura symptoms, as it can limit compensatory vasodilation. Controlling modifiable risk factors – blood pressure, blood sugar, smoking, and body weight – is equally important.

Women with migraine with aura should discuss contraception carefully with their physicians. Progestogen-only pills, hormonal IUDs, and non-hormonal methods are generally the recommended alternatives to combined estrogen-containing contraceptives.

The broader migraine-stroke relationship 🔗

Migrainous infarction is the most direct form of migraine-related stroke, but it is not the only way the two conditions intersect. A prospective cohort study of over 63,000 migraineurs found that people with migraine had a 2.5 times greater risk of developing acute ischemic stroke compared to those without migraine. Among individuals under 50, migraine-associated strokes account for about 25% of all strokes in that age group.

Strokes can also occur separately from a migraine attack, linked through shared mechanisms including endothelial dysfunction, arterial dissection, and cardioembolism. Rare genetic conditions such as CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) and MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) further illustrate how deeply the biology of migraine and cerebrovascular disease can overlap at a genetic level.

Understanding this relationship is not meant to alarm people who have migraines – the absolute risk of stroke remains low, particularly in otherwise healthy individuals. But for those with migraine with aura, especially younger women, awareness of the compounding risks posed by smoking or estrogen-containing contraceptives is genuinely protective. Knowing when an aura is lingering too long, and treating it as a medical emergency, could be the difference between a full recovery and lasting neurological damage.

What do you think? If someone with recurring migraines with aura has no other known vascular risk factors, at what point should they start proactive neurological evaluation? And given the overlap between migraine aura symptoms and early stroke warning signs, how should people be educated to tell the difference in real time?

References

1. https://pubmed.ncbi.nlm.nih.gov/38307663/
2. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1435208/full
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC3049472/
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC7553730/
5. https://journals.sagepub.com/doi/10.1111/j.1468-2982.2007.01407.x
6. https://pmc.ncbi.nlm.nih.gov/articles/PMC6814312/
7. https://en.wikipedia.org/wiki/Migrainous_infarction
8. https://www.ajog.org/article/s0002-9378(16)46208-3/fulltext
9. https://www.rush.edu/news/why-birth-control-and-migraines-aura-dont-mix
10. https://pmc.ncbi.nlm.nih.gov/articles/PMC5662520/
11. https://pubmed.ncbi.nlm.nih.gov/8374945/
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC11432473/